Publication | Open Access

Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients

Lymphoid NeoplasiaCancer ImmunosurveillanceMitomycin CMedicineImmunologyCell DeathLymphokine-activated Killer CellsImmune Checkpoint InhibitorCancer PatientsMetronomic ChemotherapyImmunotherapyOncologyCell BiologyTumor MicroenvironmentCancer Research